U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225517) titled 'A Study to Learn More About the Safety of BIIB145 and How it is Processed in the Body of Healthy Adult Participants' on Nov. 04.
Brief Summary: In this study, researchers will learn for the first time about the safety of a study drug called BIIB145 and how the body responds to it. This is a "Phase 1" study. This kind of study is an early step in clinical research where the goal is to focus on the safety of the study drug. Another goal may be to learn how the study drug is processed by the body. BIIB145 was designed to help people with multiple sclerosis (MS). But, before it can be tested in people with MS, it must first be tested in ...